Diabetic retinopathy is associated with oxidative stress and mitigation of gene expression of antioxidant enzymes

International Journal of General Medicine

Volumn 6, Issue , 2013, Pages 799-806

  El Bab, Mohamed Fath ^a,b   Zaki, Nashaat S ^a,c   Mojaddidi, Moaz A ^a   AL Barry, Maan ^a   El Beshbishy, Hesham A ^a,d  

^a TAIBAH UNIVERSITY   (Saudi Arabia)

^b SUEZ CANAL UNIVERSITY   (Egypt)

^c MANSOURA UNIVERSITY   (Egypt)

^d AL AZHAR UNIVERSITY   (Egypt)

Author keywords

Antioxidant enzymes; Diabetic retinopathy; Gene expression

Indexed keywords

ANTIOXIDANT; CATALASE; GLUCOSE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PREVALENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84884724765     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S40665     Document Type: Article

References (45)

1. Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care. 2003;26(9):2653-2664.
2. Hallman DM, Huber JC Jr, Gonzalez VH, Klein BE, Klein R, Hanis CL. Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County Texas. Diabetes Care. 2005; 28(5):1163-1168.
3. Uhlmann K, Kovacs P, Boettcher Y, Hammes HP, Paschke R. Genetics of diabetic retinopathy. Exp Clin Endocrinol Diabetes. 2006;114(6): 275-294.
4. Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA. 2003;290(15):2057-2060.
5. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102(4):527-532.
6. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102(4):520-526.
7. Heintz E, Wiréhn AB, Peebo BB, Rosenqvist U, Levin LA. Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden. Diabetologia. 2010;53(10):2147-2154.
8. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010; 376(9735):124.
9. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115(11):1859-1868.
10. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. JAMA. 2002;287(19):2563-2569.
11. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577-1589.
12. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 1995;18(2):258-268.
13. Chew EY, Klein ML, Ferris FL, et al. Association of elevated serum lipid levels with retinal hard exudates in diabetic retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol. 1996;114(9):1079-1084.
14. Fujisawa T, Ikegami H, Yamato E, etal. Association of plasma fibrinogen level and blood pressure with diabetic retinopathy, and renal complications associated with proliferative diabetic retinopathy in Type II diabetes mellitus. Diabet Med. 1999;16(6):522-526.
15. Zhang X, Saaddine JB, Chou CF, Cotch MF, etal. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304(6): 649-656.
16. Hammes HP, Kerner W, Hofer S, Kordonouri O, Raile K, Holl RW; DPV-Wiss Study Group. Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8784 patients. Diabetologia. 2011;54(8): 1977-1984.
17. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2004.27 Suppl 1:S5-S10.
18. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care. 2008;31 Suppl 1:S12-S54.
19. Tam VH, Lam EP, Chu BC, Tse KK, Fung LM. Incidence and progression of diabetic retinopathy in Hong Kong Chinese with type 2 diabetes mellitus. J Diabetes Complications. 2009;23(3):185-193.
20. Wilkinson CP, Ferris FL 3rd, Klein RE, etal. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110:1677-1682.
21. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.
22. Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat liver. 1976. Biochem Biophys Res Commun. 2012;425(3): 503-509.
23. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121-126.
24. Oyanagui Y. Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. Anal Biochem. 1984;142(2): 290-296.
25. Stratton IM, Kohner EM, Aldington SJ, etal. UKPDS 50: Risk factors for incidence and progression of retinopathy in Type 2 diabetes over 6 years from diagnosis. Diabetologia. 2001;44(2):156-163.
26. Dimitrov PN, Mukesh BN, McCarty CA, Taylor HR. Five-year incidence of diabetic retinopathy in the Melbourne Visual Impairment Project. Clin Experiment Ophthalmol. 2003;31(5):397-402.
27. El-Bab MF, Shawky N, Al-Sisi A, Akhtar M. Retinopathy and risk factors in diabetic patients from Al-Madinah Al-Munawarah in the Kingdom of Saudi Arabia. Clin Ophthalmol. 2012;6:269-276.
28. Looker HC, Krakoff J, Knowler WC, Bennett PH, Klein R, Hanson RL. Longitudinal studies of incidence and progression of diabetic retinopathy assessed by retinal photography in pima Indians. Diabetes Care. 2003;26(2):320-326.
29. Tam TK, Lau CM, Tsang LC, Ng KK, Ho KS, Lai TC. Epidemiological study of diabetic retinopathy in a primary care setting in Hong Kong. Hong Kong Med J. 2005;11(6):438-444.
30. Chen MS, Kao CS, Fu CC, Chen CJ, Tai TY. Incidence and progression of diabetic retinopathy among non-insulin dependent diabetic subjects: A 4-year follow-up. Int JEpidemiol. 1995;24(4):787-795.
31. Shiraiwa T, Kaneto H, Miyatsuka T, etal. Postprandial hyperglycemia is a better predictor of the progression of diabetic retinopathy than HbA1c in Japanese type 2 diabetic patients. Diabetes Care. 2005;28(11): 2806-2807.
32. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317(160):703-713.
33. Schrier RW, Estario RO, Jeffers B. Appropriate blood pressure control in NIDDM (ABCD) Trial. Diabetologia. 1996;39(12):1646-1654.
34. Leske MC, Wu SY, Hennis A, etal Barbados Eye Study Group. Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: the Barbados Eye Studies. Ophthalmology. 2005;112(5): 799-805.
35. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology. 2009;116(3):497-503.
36. Srivastava BK. Rema M. Does hypertension play a role in diabetic retinopathy? J Assoc Physicians India. 2005;53:803-808.
37. Bhatnagar A, Ghauri AJ, Hope-Ross M, Lip PL. Diabetic retinopathy in pregnancy. Curr Diabetes Rev. 2009;5(3):151-156.
38. Janghorbani M, Jones RB, Murray KJ, Allison SP. Incidence of risk factors for diabetic retinopathy in diabetic clinic attenders. Ophthalmic Epidemiol. 2001;8(5):309-325.
39. Chan WB, Tong PC, Chow CC, etal. The associations of body mass index, C-peptide and metabolic status in Chinese Type 2 diabetic patients. Diabetic Med. 2004;21:349-353.
40. Klein BE, Moss SE, Klein R, Surawicz TS. Wisconsin Epidemiologic Study of Diabetic Retinopathy: XIII. Relationship of serum cholesterol to retinopathy and hard exudates. Ophthalmology. 1991;98(8): 1261-1265.
41. Gupta A, Gupta V, Thapar S, Bhansali A. Lipid lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. Am J Ophthal. 2004;137(4):675-682.
42. Carson AP, Reynolds K, Fonseca VA, Muntner P. Comparison of A1c and fasting glucose criteria to diagnose diabetes among US adults. Diabetes Care. 2010;33:95-97.
43. Elchuri S, Oberley TD, Qi W, etal. CuZn-SOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene. 2005;24(3):367-380.
44. Muller FL, Song W, Liu Y, etal. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age dependent skeletal muscle atrophy. Free Radic Biol Med. 2006;40(11):1993-2004.
45. Matsunami T, Sato Y, Sato T, Yukawa M. Antioxidant status and lipid peroxidation in diabetic rats under hyperbaric oxygen exposure. Physiol Res. 2010;59(1):97-104.